مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

377
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

169
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

BIOEQUIVALENCE COMPARISON OF TWO FORMULATIONS OF FIXED-DOSE COMBINATION GLIMEPIRIDE/METFORMIN (2/500 MG)TABLETS IN HEALTHY VOLUNTEERS

Pages

  365-371

Abstract

 Glimepiride/METFORMIN (2.500 mg) is an oral antihyperglycemic agent for the treatment of type 2 diabetes. A generic GLIMEPIRIDE/METFORMIN (2.500 mg) fixed-dose combination (FDC) tablet was developed recently. This study was designed to collect data for submission to Korean regulatory authorities to allow the marketing of the test formulation. We evaluated the comparative bioavailability and tolerability of the test and reference formulations in healthy male adult volunteers. This single-dose, randomized, double-blind, two-way crossover trial was conducted at Bestian Medical Center in Bucheon, Korea. In total, 40 male Korean volunteers were enrolled. The subjects were randomized to receive an FDC tablet containing the GLIMEPIRIDE/METFORMIN (2.500 mg) test or reference formulation, and pharmacokinetic (PK) parameters were measured. After a 1-week washout period, the other formulation was administered and the PK parameters were measured again. The Cmax and AUCt were determined from blood samples obtained at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 5, 6, 8, 12, and 24 h after drug administration. BIOEQUIVALENCE was considered established if the 90% CIs of the geometric mean ratios (GMRs) of the test-to-reference formulations for Cmax and AUCt were within the predetermined regulatory range of 80-125%. Intotal, 40 healthy male subjects were enrolled and completed the study (mean [SD] age, 23.2 [2.26] years [range, 19-30years]; weight, 68.95 [8.30] Kg [range, 52.0-87.0 Kg]; and height, 175.4 [5.34] cm [range, 164-189 cm]). The GMRs (90% CI) of the GLIMEPIRIDE Cmax and AUCt were 1.006 (0.947-1.069) and 1.010 (0.953-1.071), respectively. For METFORMIN, the values were 1.019 (0.959-1.083) and 1.035 (0.989-1.084), respectively. The test and reference formulations had similar PK parameters. The test formulation of GLIMEPIRIDE/METFORMIN (2.500 mg) FDC tablets met the Korean regulatory criteria for BIOEQUIVALENCE.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    JUNG, SANG HOON, CHAE, JUNG WOO, SONG, BYUNG JEONG, & KWONA, KWANG IL. (2014). BIOEQUIVALENCE COMPARISON OF TWO FORMULATIONS OF FIXED-DOSE COMBINATION GLIMEPIRIDE/METFORMIN (2/500 MG)TABLETS IN HEALTHY VOLUNTEERS. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), 13(2), 365-371. SID. https://sid.ir/paper/288232/en

    Vancouver: Copy

    JUNG SANG HOON, CHAE JUNG WOO, SONG BYUNG JEONG, KWONA KWANG IL. BIOEQUIVALENCE COMPARISON OF TWO FORMULATIONS OF FIXED-DOSE COMBINATION GLIMEPIRIDE/METFORMIN (2/500 MG)TABLETS IN HEALTHY VOLUNTEERS. IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR)[Internet]. 2014;13(2):365-371. Available from: https://sid.ir/paper/288232/en

    IEEE: Copy

    SANG HOON JUNG, JUNG WOO CHAE, BYUNG JEONG SONG, and KWANG IL KWONA, “BIOEQUIVALENCE COMPARISON OF TWO FORMULATIONS OF FIXED-DOSE COMBINATION GLIMEPIRIDE/METFORMIN (2/500 MG)TABLETS IN HEALTHY VOLUNTEERS,” IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH (IJPR), vol. 13, no. 2, pp. 365–371, 2014, [Online]. Available: https://sid.ir/paper/288232/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button